On October 31, 2017, Gregg A. Lapointe was appointed to serve on Rigel Pharmaceuticals, Inc. board of directors until his successor is elected and has qualified, or sooner in the event of his death, resignation or removal. Mr. Lapointe joins the class of directors whose term expires at the 2018 annual stockholders' meeting. Mr. Lapointe was also appointed to serve on the Audit Committee of company board of directors.